Shenzhen Hepalink Pharmaceutical Group , Ltd. Inventory

Shenzhen Hepalink Pharmaceutical Group , Ltd. (9989.HK) currently reports a inventory of $3.9B as of June 2026. That compares with $4.7B in the prior-year period — down 16.0% year over year. Use the charts on this page to explore Shenzhen Hepalink Pharmaceutical Group , Ltd.'s inventory history and peer comparisons.

Shenzhen Hepalink Pharmaceutical Group , Ltd.'s inventory decreased from $4.7B to $3.9B — a 16.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Shenzhen Hepalink Pharmaceutical Group , Ltd. reported $3.9B in inventory as of June 2026. That compares with $4.7B in the prior-year period — down 16.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $3.9B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Shenzhen Hepalink Pharmaceutical Group , Ltd., and consider following 9989.HK for alerts when major investors trade the stock.